SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
威武的匕
Lv2
1
130 积分
2023-11-08 加入
最近求助
最近应助
互助留言
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
6小时前
已完结
Medications for Obesity
6小时前
已完结
Tirzepatide for Obesity Treatment and Diabetes Prevention
4天前
已完结
PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study
2个月前
已完结
Adjunctive PCSK9 Inhibitor Evolocumab in the Prevention of Early Neurological Deterioration in Non-cardiogenic Acute Ischemic Stroke: A Multicenter, Prospective, Randomized, Open-Label, Clinical Trial
2个月前
已完结
Association of proprotein convertase subtilisin/kexin type-9 inhibitors with risk of nonmelanoma skin cancer: a retrospective cohort study
2个月前
已关闭
PCSK9 Inhibition could be Effective for Acute Myocardial Infarction
3个月前
已完结
The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease
3个月前
已完结
Disruption of PCSK9 Suppresses Inflammation and Attenuates Abdominal Aortic Aneurysm Formation
3个月前
已完结
Emerging roles of PCSK9 in kidney disease: lipid metabolism, megalin regulation and proteinuria
3个月前
已完结
没有进行任何应助
感谢
2个月前
感谢
2个月前
已求助过【积分已退回】
2个月前
速度真快
8个月前
速度真快
8个月前
感谢
8个月前
感谢
1年前
感谢
1年前
感谢
1年前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论